CClinicalTrials.gg
CompletedNCT03446560Updated Jan 14, 2020

Cloud Based Follow up of CPAP Treatment

An interventional study of CPAP, conventional follow up and CPAP, telemedicine based follow up in Sleep Apnea Syndromes, sponsored by Vastra Gotaland Region. Completed at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-01-14.

Sponsored by Vastra Gotaland Region · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
403
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Obstructive sleep apnea (OSA) is treated with a continuous positive airway pressure, so called CPAP. A new technology that enables telemetric monitoring of CPAP therapy. This study randomizes 560 patients to A) conventional follow up procedures or B to a telemedicine based follow up procedure. Main endpoint parameter is CPAP treatment compliance at 3 months after start of treatment.

Read the detailed description

Background:

Obstructive sleep apnea (OSA) is treated with a continuous positive airway pressure, so called CPAP, during sleep. CPAP startup and follow-up is performed at four sleep clinics in the West Swedish Region (SU / S, SÄS, SkaS, NÄL). Patient volumes are high, waiting times are long and long-term follow-up is inconsistent. A new technology that enables telemetric monitoring of CPAP therapy based on transfer of therapy data to a data cloud has been introduced. Healthcare personnel can identify patients with therapy problems.

Data from minor studies suggest several benefits of this telemedicine solution (increased therapeutic capacity, lower patient and community costs and a time benefit for the sleep medicine unit). Today, the sleep Clinical in the region use different procedures for monitoring CPAP treatment.

Scientific question:

Is telemedicine monitoring of CPAP treatment an adequate solution for follow up in all patients ? Is the additional cost of a telemedicine solution balanced by a better outcome after therapy?

Hypothesis:

Intensive telemedicine monitoring, especially at the start of CPAP therapy, leads to improved CPAP care at the participating sleep units.

Method:

The study randomizes 560 patients (moderate to severe sleep apnea) to different CPAP treatment follow up procedures: A) the current routine of the sleep clinic or B) the new telemedicine solution (1: 1 randomization). The main outcome parameter of the study is the mean CPAP use after 3 months of treatment. Secondary outcome parameters include the reduction of sleep apnea intensity, daytime sleepiness, and patient-related outcome measures (PROM).

Aim:

The aim of the study is to map the pros and cons of a telemedicine solution in CPAP therapy regarding treatment outcomes, patient quality of life and resource utilization at the sleep center.

02

Conditions studied

  • Sleep Apnea Syndromes

Keywords

  • Compliance
  • Telemedicine
  • Patient related outcome measures
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Verified sleep apnea diagnosis according to ICSD II criteria
  • Indication for CPAP treatment according to Swedish national guidelines
  • Capacity to read and understand the Swedish language
  • Willingness to test CPAP treatment

Exclusion criteria

Exclusion Criteria:

  • Instable concomitant disease requiring frequent hospitalization
  • Alcohol and drug abuse
  • Non-availability during the follow up during 3 months (e.g. frequent or long-term travelling)
  • Hypoventilation syndrome with PCO2>7kpa
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
403 participants (actual)

Study arms

  • Active comparator
    CPAP, conventional follow up

    Follow up of patients after initiation of treatment according to clinical routine at the study site.

    Device: CPAP, conventional follow up

  • Active comparator
    CPAP, telemedicine based follow up

    Follow up of patients after initiation of treatment according to a telemedicine based routine.

    Device: CPAP, telemedicine based follow up

Interventions

  • DeviceCPAP, conventional follow up

    Positive airway pressure to splint the airway and to prevent apneas during sleep. Follow up of patients after initiation of treatment according to clinical routine at the study site. Patients are informed to call or visit the sleep center in case of problems with the CPAP device. At 3 months a follow up visit is scheduled at the sleep center. CPAP compliance data will be downloaded and all patients fill in a number of questionaires related to the CPAP treatment effects on sleep apnea symptoms and health related quality of Life. Mask fitting will be tested.

  • DeviceCPAP, telemedicine based follow up

    Follow up of patients by means of a telemedicine solution for surveillance of CPAP treatment, Compliance with and efficacy of CPAP can be followed up by the sleep center personnel on a regular basis. Patients with low compliance and mask fitting problems will be contacted by phone. At the end of the 3 months period a visit at the sleep center will be scheduled only for patients with low compliance, low treatment efficacy, or high mask leakage. All patients will be asked to fill in a number of questionaires related to CPAP treatment effects on sleep apnea symptoms and health related quality of Life.

05

What researchers measure

Primary outcomes

  1. CPAP treatment compliance at 3 months

    Mean nightly use of CPAP treatment (h/night) according to the built in time counter of the CPAP device, between group difference

    Time frame: 3 months

Secondary outcomes

  1. Reduction of daytime sleepiness

    Reduction of the score in the Epworth Sleepiness Scale Score (range 0-24, 0=no sleepiness, 24=very high sleepiness, summary score from 8 different questions about the probability of daytime sleepiness, each question can generate between 0=unlikely and 4=highly likely points), assessment at baseline and at follow up, between group difference

    Time frame: 3 months

  2. Reduction of the degree of sleep apnea

    Between Group difference in the reduction of the Apnea Hypopnea Index (n/h) from baseline (no treatment) to follow up (with CPAP on)

    Time frame: 3 months

  3. Non Acceptance Rate of CPAP therapy

    Proportion of patients refusing CPAP therapy, between group difference

    Time frame: 3 months

  4. Health care utilization during follow up

    Time spent for follow up procedures by the Health care personel, between group difference

    Time frame: 3 months

  5. Patient satisfaction regarding the follow up procedure

    Visual Analogue Scale (VAS) Rating of patient satisfaction with the two different follow up procedures, VAS scale has 0 to 100 Points where 0=very low satisfaction and 100= very high satisfaction, no subscales.

    Time frame: 3 months

Other outcomes

  1. Degree of comorbid depression and anxiety symptoms

    Score of the Hospital Anxiety and Depression Scale (HADS) pre and post treatment, between group differences. The HADS scale consists of 7 questions for anxiety rating (each question can generate 0-1 Point), the points from each question will be summarized to a total score with has a range of 0-21 (0=no anxiety and 21=severe anxiety). The depression rating is performed according to the same principle (seven questions, summary score with a range 0 to 21).

    Time frame: 3 months

  2. Degree of comorbid insomnia

    Score of the Insomnia Severity Index (ISI) Score pre and post treatment, between group differences. The questionnaire consists of 7 questions, each generating 0 (no insomnia problem) or up to 4 (very severe insomnia problems) Points. The 7 questions can generate a summary score between 0 and 28.

    Time frame: 3 months

06

Study locations

1 site
  • Sahlgrenska University Hospital, Sleep Disorders Center
    Gothenburg, 41345, Sweden
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03446560
Lead sponsor
Vastra Gotaland Region
Collaborators
Borås Lasarett, Skaraborgs Hospital, NU-Hospital Organization, Sweden
Responsible party
Ludger Grote (MD, Senior Consultant, Professor, Vastra Gotaland Region) — Principal investigator
First posted
Feb 27, 2018
Start date
Jan 1, 2018
Primary completion
Apr 30, 2019
Completion
Dec 23, 2019
Last update
Jan 14, 2020

Study contacts

Ludger Grote
principal investigator · Respiratory Medicine, Sahlgrenska University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion